<DOC>
	<DOCNO>NCT01822379</DOCNO>
	<brief_summary>Previous study evaluate transplantation pigment cell ( melanocyte ) skin cell ( keratinocytes ) treatment vitiligo . This procedure know MKTP ( Melanocyte Keratinocyte Transplantation Procedure ) . Multiple study find procedure safe effective treatment vitiligo . The majority study utilize trypsin help isolate melanocyte keratinocytes . Trypsin enzyme help separate different layer skin . However , cell biologist believe enzyme dispase ( use separate epidermis dermis ) less toxic cell epidermis result great number viable melanocyte keratinocytes transplantation . This study look repigmentation rate MKTP use trypsin isolate cell , versus MKTP use dispase isolate cell .</brief_summary>
	<brief_title>Comparative Study Techniques Melanocyte-Keratinocyte Transplantation Treatment Vitiligo</brief_title>
	<detailed_description />
	<mesh_term>Vitiligo</mesh_term>
	<criteria>1 . Be least 18 year old 2 . Have diagnosis generalize vitiligoâ€”vitiligo affect side body one area body ( extremity , trunk , etc . ) 3 . Have stable vitiligo , define new lesion development ( expansion exist lesion ) 6 month prior propose procedure date 4 . Be able understand requirement study , risk involve , able sign inform consent form 5 . Agree follow undergo studyrelated procedure 1 . Female patient selfreported lactate , pregnant , plan become pregnant 2 . Patients history develop vitiligo hypertrophic scar sit trauma 3 . Patients selfreported HIV Hepatitis C 4 . Patients selfreported uncontrolled Diabetes Mellitus 5 . The investigator feels patient participate study reason 6 . Patients acral vitiligo , define significant involvement finger and/or toe 7 . Patients focal segmental vitiligo , define vitiligo affect one area body one side body 8 . Patients vitiligo affect great 30 % body surface area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>